Back to Search Start Over

913-P: The Relationship between ASK12 Patient-Reported Medication Adherence Scores and Objective Measures of Adherence among Patients with Type 2 Diabetes

Authors :
PAMALA PAWLOSKI
JEANETTE ZIEGENFUSS
PATRICK J. O'CONNOR
STEVEN P. DEHMER
HEIDI EKSTROM
JACOB HAAPALA
JOANN M. SPERL-HILLEN
MARY BECKER
ANJALI TRUITT
MELISSA PANKONIN
DANIEL REHRAUER
CAITLIN FRAIL
JEFFREY ANDERSON
LILIAN CHUMBA
Source :
Diabetes. 71
Publication Year :
2022
Publisher :
American Diabetes Association, 2022.

Abstract

Background: Medication adherence may be measured either by (a) patient-reported measurement or (b) objective measurement using medication dispense data. Proportion of days covered (PDC) is an objective measure of adherence becoming more readily available in the electronic health record (EHR) and a threshold of < 80% is commonly used to identify a potential adherence problem. Using PDCs may be more efficient and clinically practical than using longer patient-reported adherence questionnaires. However, it is unknown how well the PDC and patient reported measures correlate. Methods: As part of a pragmatic randomized trial to evaluate an intervention designed to improve medication adherence in a Midwest health care system, 1,423 adults with type 2 diabetes (T2D) were identified at an index visit in primary care based on suboptimal diabetes control (AIC >8%) and at least one oral diabetes medication with PDC < 80%. They were surveyed shortly after the index visit to assess adherence using a validated 12 question ASK-12 instrument, with a response rate of 29% (80/280) . We evaluated the relationship between PDC and ASK-12 total/subscale scores using linear regression. Results: There were no significant associations found between PDC scores and the total ASK-12 score (β=-0.4, p=0.47) , or ASK-12 subscales of inconvenience/forgetfulness (β=-1.1, p=0.42) , treatment beliefs (β=-0.4, p=0.77) , behavior (β=-0.7, p=0.55) , or barriers (β=-0.7, p=0.44) . Conclusions: For patients above recommended A1C goal with a medication PDC < 80%, there was no correlation between PDC scores and patient-reported measures of adherence using ASK-12 total or component scores. This analysis raises questions about the validity and usefulness of EHR-derived PDC scores to identify poor medication adherence for patients with T2D. Disclosure P.Pawloski: None. M.Pankonin: None. D.Rehrauer: None. C.Frail: None. J.Anderson: None. L.Chumba: None. J.Ziegenfuss: None. P.J.O'connor: None. S.P.Dehmer: None. H.Ekstrom: None. J.Haapala: None. J.M.Sperl-hillen: None. M.Becker: None. A.Truitt: None. Funding NHLBI #R01HL136937

Details

ISSN :
00121797
Volume :
71
Database :
OpenAIRE
Journal :
Diabetes
Accession number :
edsair.doi...........a2ac7da6928705c570d6d26e0b41c98e
Full Text :
https://doi.org/10.2337/db22-913-p